Schizophrenia study: LB-102
Official title 52-week Open Label Safety-Tolerability Study
ClinicalTrials.gov ID: NCT07369154
What this study is testing
What is LB-102?
LB-102 is an investigational oral medication being studied for the treatment of schizophrenia.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study will look at how safe and well‑tolerated LB‑102 is over 52 weeks.
- Who it's for
- Adults who have stable schizophrenia and are already receiving treatment.
- What's involved
- Participants will take LB‑102 as prescribed and attend regular clinic visits for safety checks and blood tests.
- Time commitment
- The study lasts 52 weeks, with visits every few weeks to monitor safety and tolerability.
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Provide ICF
- Patients clinically stable PANSS \</= 80 at screening
- CGI-S \</+ 3 at screening
- Medically stable
- BMI 18 -40
You likely can't join if
- Sexually active M/F patients not willing to use highly effective contraception
- Breast feeding
- History of treatment resistance to schizophrenia medications
- DSM-5 current diagnosis other than schizophrenia
- Risk of suicidal behavior
- History or presence of clinically significant cardiovascular, pulmonary, hepatic, renal, hematologic, gastrointestinal, endocrine, immunologic...
See the full eligibility criteria
- Provide ICF
- Patients clinically stable PANSS \</= 80 at screening
- CGI-S \</+ 3 at screening
- Medically stable
- BMI 18 -40
- Taking oral antipsychotic treatment for at least 30 days
- Have stable living environment
- Sexually active M/F patients not willing to use highly effective contraception
- Breast feeding
- History of treatment resistance to schizophrenia medications
- DSM-5 current diagnosis other than schizophrenia
- Risk of suicidal behavior
- History or presence of clinically significant cardiovascular, pulmonary, hepatic, renal, hematologic, gastrointestinal, endocrine, immunologic, dermatologic, neurologic, or oncologic disease or any other
The study team makes the final eligibility decision.
Where it is enrolling
- Chandler, Arizona, United States
- Bentonville, Arkansas, United States
- Little Rock, Arkansas, United States
- Anaheim, California, United States
- Cerritos, California, United States
- Culver City, California, United States
- San Diego, California, United States
- Hollywood, Florida, United States
- Miami Lakes, Florida, United States
- West Palm Beach, Florida, United States
- Atlanta, Georgia, United States
- Snellville, Georgia, United States
- Chicago, Illinois, United States
- Gaithersburg, Maryland, United States
- St Louis, Missouri, United States
- Las Vegas, Nevada, United States
- New York, New York, United States
- Canton, Ohio, United States
- Philadelphia, Pennsylvania, United States
- DeSoto, Texas, United States
+ 1 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Chandler, Arizona, United States; Bentonville, Arkansas, United States; Little Rock, Arkansas, United States; Anaheim, California, United States; Cerritos, California, United States; Culver City, California, United States and 15 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.